Ganciclovir (GCV)

DRUG5 trials

Sponsors

University of Alabama at Birmingham, Chunxiao Wang, Al-Azhar University, Amivas Inc., Peking University People's Hospital

Conditions

CMVCMV InfectionHerpes Simplex KeratitisHerpetic KeratitisOvarian CancerSLE (Systemic Lupus)

Phase 1

A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers

CompletedNCT00964756

University of Alabama at BirminghamOvarian Cancer

Start: 2009-08-31End: 2012-04-30Updated: 2013-02-13

Phase 2

Study Evaluating the Efficacy and Safety of Artesunate

RecruitingNCT06853184

Amivas Inc.CMV Infection

Start: 2025-08-01End: 2028-06-30Target: 90Updated: 2025-10-20

Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

Not yet recruitingNCT06971913

Peking University People's HospitalCMV, SLE (Systemic Lupus)

Start: 2025-05-20End: 2025-12-30Target: 100Updated: 2025-05-14

Unknown Phase

Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis

Chunxiao WangHerpes Simplex Keratitis

Start: 2017-07-20End: 2019-12-30Target: 100Updated: 2018-02-22

Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis

CompletedNCT06757907

Al-Azhar UniversityHerpetic Keratitis

Start: 2024-10-01End: 2024-12-25Updated: 2025-01-03